Resultado de búsqueda
Richard THOMPSON | Cited by 6,962 | of Johns Hopkins Bloomberg School of Public Health, MD (JHSPH) | Read 114 publications | Contact Richard THOMPSON
16 de mar. de 2021 · Abstract. It is unclear why some SARS-CoV-2 patients readily resolve infection while others develop severe disease. By interrogating metabolic programs of immune cells in severe and recovered coronavirus disease 2019 (COVID-19) patients compared with other viral infections, we identify a unique population of T cells.
Richard Koup is the deputy director of the Vaccine Research Center and the chief of the Immunology Laboratory at NIAID. He studies the cellular immune response to HIV and other viral pathogens and leads clinical trials of prophylactic and therapeutic vaccines.
Richard Thompson. Senior Scientist. Bloomberg School of Public Health; 2000 2024. Research activity per year. Overview; Fingerprint; Network; Research output (151) Similar Profiles (1) Fingerprint. Dive into the research topics where Richard Thompson is active. These topic labels come from the works of this person.
Research Interests. Biostatistics, Computing; environmental statistics; risk assessment; mathematical modeling; statistical computing.
23 de abr. de 2024 · Richard Childs is a Senior Investigator and Clinical Director of the NHLBI, specializing in bone marrow transplantation and tumor immunotherapy. He has conducted research on graft-vs-tumor effects, HERV-E antigens, and NK cell therapy for various cancers.
Richard E. Thompson. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health. ... DF Hanley, RE Thompson, M Rosenblum, G Yenokyan, K Lane, N McBee, ... The Lancet 393 (10175), 1021-1032, 2019. 632: 2019: Kindergarten predictors of math learning disability.
